Alleo and Ubiquigent unite to accelerate drug discovery
15th October 2024 Uncategorised 0Partnership to harness AI for DUB-focused preclinical programmes More: Alleo and Ubiquigent unite to accelerate drug discovery Source: News
read more
Partnership to harness AI for DUB-focused preclinical programmes More: Alleo and Ubiquigent unite to accelerate drug discovery Source: News
read moreVanda, despite FDA rejection, swats down another buyout bid from Cycle kdunleavy Mon, 10/14/2024 – 14:52 More: Vanda, despite FDA rejection, swats down another buyout bid from Cycle Source: fierce
read moreOn road to crowded Crohn’s disease market, Lilly’s Omvoh bests J&J’s Stelara in head-to-head study zbecker Mon, 10/14/2024 – 11:26 More: On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study Source: fierce
read moreLeqembi’s vial design could result in hundreds of millions in annual Medicare waste: study aliu Mon, 10/14/2024 – 11:04 More: Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study Source: fierce
read moreSamsung Biologics’ Manufacturing Capabilities for Complex Biomedicines jpiatt Mon, 10/14/2024 – 10:34 More: Samsung Biologics’ Manufacturing Capabilities for Complex Biomedicines Source: fierce
read moreIncyte picks Dr. Pimple Popper to expand Opzelura atopic dermatitis campaign apark Mon, 10/14/2024 – 10:24 More: Incyte picks Dr. Pimple Popper to expand Opzelura atopic dermatitis campaign Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals